Biofrontera Balance Sheet Health
Financial Health criteria checks 6/6
Biofrontera has a total shareholder equity of €17.9M and total debt of €39.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are €24.2M and €6.3M respectively.
Key information
0.2%
Debt to equity ratio
€39.00k
Debt
| Interest coverage ratio | n/a |
| Cash | €2.21m |
| Equity | €17.86m |
| Total liabilities | €6.32m |
| Total assets | €24.18m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B8FK's short term assets (€12.8M) exceed its short term liabilities (€5.9M).
Long Term Liabilities: B8FK's short term assets (€12.8M) exceed its long term liabilities (€466.0K).
Debt to Equity History and Analysis
Debt Level: B8FK has more cash than its total debt.
Reducing Debt: B8FK's debt to equity ratio has reduced from 77.4% to 0.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: B8FK has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: B8FK is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.